ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis
- 31 January 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (1), 69-78
- https://doi.org/10.1016/j.ajpath.2010.11.029
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R01-CA129343)
- Eli Lilly
- Programme Hospitalier de Recherche Clinique 2005
- Cancéropôle Rhône-Alpes
This publication has 31 references indexed in Scilit:
- Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- In SituProtein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based ChemotherapyCancer Investigation, 2009
- Non–Small Cell Lung Cancer Exhibits Transcript Overexpression of Genes Associated with Homologous Recombination and DNA Replication PathwaysCancer Research, 2009
- BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung CancerPLOS ONE, 2007
- Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancerInternational Journal of Cancer, 2006
- ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineAnnals Of Oncology, 2006
- DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant ChemotherapyNew England Journal of Medicine, 2006
- Suppression of Lung Tumor Formation by the Regulatory Subunit of Ribonucleotide ReductaseCancer Research, 2006
- An Increase in the Expression of Ribonucleotide Reductase Large Subunit 1 Is Associated with Gemcitabine Resistance in Non-Small Cell Lung Cancer Cell LinesCancer Research, 2004
- Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysisCarcinogenesis: Integrative Cancer Research, 2000